Highlights
- Mass administration of ivermectin is associated with lower COVID-19 incidence.•
- Ivermectin has been shown to inhibit SARS-CoV-2 replication in vitro.•
- Ivermectin may have a prophylactic effect against COVID-19.•
- COVID-19 prophylaxis could help bridge the time until a vaccine becomes widely available.
As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence but also to provide guidance for potential treatments elsewhere. Such a treatment would be particularly valuable if it could be used as a prophylactic against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) transmission, thereby effectively slowing the spread of the disease while we await the wide availability of safe and effective vaccines.
>> Read the full article: https://www.sciencedirect.com/science/article/pii/S0924857920304684
Coronavirus Exposed 